Related references
Note: Only part of the references are listed.Mortality caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia; a case control study: alert to Enterobacteriaceae strains with high minimum inhibitory concentrations of piperacillin/tazobactam
Hiroki Namikawa et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2019)
Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study
Qing Zhang et al.
INFECTION AND DRUG RESISTANCE (2019)
Risk factors for community-onset bloodstream infection with extended-spectrum β-lactamase-producing Enterobacteriaceae: national population-based case-control study
J. Isendahl et al.
CLINICAL MICROBIOLOGY AND INFECTION (2019)
Carbapenem versus Cefepime or Piperacillin-Tazobactam for Empiric Treatment of Bacteremia Due to Extended-Spectrum-β-Lactamase-Producing Escherichia coli in Patients with Hematologic Malignancy
Grace E. Benanti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae infection causing septic shock in cancer patients with chemotherapy-induced febrile neutropenia
Youn-Jung Kim et al.
INTERNAL AND EMERGENCY MEDICINE (2019)
Associated factors and clinical outcomes of bloodstream infection due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae during febrile neutropenia
Eli Ben-Chetrit et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria
C. Cattaneo et al.
ANNALS OF HEMATOLOGY (2018)
Bloodstream infections in cancer patients. Risk factors associated with mortality
Beda Islas-Munoz et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2018)
Risk factors for bloodstream infections due to extended-spectrum β-lactamase producing Enterobacteriaceae in cancer patients
Sabahat Ceken et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2018)
Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy
Michail Alevizakos et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2017)
Bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae among patients with malignancy: a systematic review and meta-analysis
Michail Alevizakos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2017)
Antimicrobial resistance patterns, clinical features, and risk factors for septic shock and death of nosocomial E coli bacteremia in adult patients with hematological disease A monocenter retrospective study in China
Jie Ma et al.
MEDICINE (2017)
Efficacy of β-Lactam/β-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in Hematological Patients with Neutropenia
Carlota Gudiol et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients: results of a prospective study by the Rete Ematologica Lombarda (Rel)
Chiara Cattaneo et al.
ANNALS OF HEMATOLOGY (2016)
Colonisation with extended-spectrum β-lactamase-producing Enterobacteriaceae and risk for infection among patients with solid or haematological malignancy: a systematic review and meta-analysis
Michail Alevizakos et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies
Michael J. Satlin et al.
JOURNAL OF INFECTION (2016)
Bloodstream infections in patients with solid tumors
Carlota Gudiol et al.
VIRULENCE (2016)
Colonization and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients - Review of the literature from a clinical perspective
Lena M. Biehl et al.
CRITICAL REVIEWS IN MICROBIOLOGY (2016)
Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal
Awa Ndir et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2016)
Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Bacteremia in Febrile Neutropenic Children
Seung Beom Han et al.
MICROBIAL DRUG RESISTANCE (2015)
Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients
Marta Bodro et al.
SUPPORTIVE CARE IN CANCER (2014)
Prevalence and impact of extended-spectrum β-lactamase production on clinical outcomes in cancer patients with Enterobacter species bacteremia
Sun Jong Kim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2014)
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome
Si-Hyun Kim et al.
ANNALS OF HEMATOLOGY (2013)
Factors influencing the early mortality in haematological malignancy patients with nosocomial Gram negative bacilli bacteraemia: a retrospective analysis of 154 cases
Gokhan Metan et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer
Young Eun Ha et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2013)
Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance
S. Schelenz et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?
Konstantinos Z. Vardakas et al.
JOURNAL OF INFECTION (2013)
Outcomes and risk factors for mortality in community-onset bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli, with a special emphasis on antimicrobial therapy
Cheol-In Kang et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2013)
Risk factors for infection and treatment outcome of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy
Cheol-In Kang et al.
ANNALS OF HEMATOLOGY (2012)
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum -lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
Wouter C. Rottier et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Molecular Analysis and Risk Factors for Escherichia coli Producing Extended-Spectrum β-Lactamase Bloodstream Infection in Hematological Malignancies
Patricia Cornejo-Juarez et al.
PLOS ONE (2012)
Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae
Shu-Shen Wang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Bacteraemia due to extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome
Carlota Gudiol et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies
Enrico M. Trecarichi et al.
JOURNAL OF INFECTION (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
Alessandro Liberati et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Extended-spectrum beta-lactamase-producing enterobacteriaceae: an emerging public-health concern
Johann D. D. Pitout et al.
LANCET INFECTIOUS DISEASES (2008)
Extended-spectrum β-lactamases:: a clinical update
DL Paterson et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Share Paper
